KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to $12.4 billion.

  • Vertex Pharmaceuticals' Retained Earnings rose 4227.27% to $12.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 billion, marking a year-over-year increase of 4227.27%. This contributed to the annual value of $9.6 billion for FY2024, which is 528.08% down from last year.
  • Vertex Pharmaceuticals' Retained Earnings amounted to $12.4 billion in Q3 2025, which was up 4227.27% from $11.3 billion recorded in Q2 2025.
  • Vertex Pharmaceuticals' Retained Earnings' 5-year high stood at $12.4 billion during Q3 2025, with a 5-year trough of $1.5 billion in Q1 2021.
  • Moreover, its 5-year median value for Retained Earnings was $7.6 billion (2024), whereas its average is $7.1 billion.
  • Its Retained Earnings has fluctuated over the past 5 years, first skyrocketed by 85515.11% in 2021, then tumbled by 879.65% in 2025.
  • Vertex Pharmaceuticals' Retained Earnings (Quarter) stood at $3.2 billion in 2021, then surged by 103.79% to $6.5 billion in 2022, then surged by 55.49% to $10.1 billion in 2023, then dropped by 5.28% to $9.6 billion in 2024, then rose by 28.75% to $12.4 billion in 2025.
  • Its Retained Earnings was $12.4 billion in Q3 2025, compared to $11.3 billion in Q2 2025 and $10.3 billion in Q1 2025.